Loading clinical trials...
Loading clinical trials...
Nonsense Mutation Aniridia: An Ataluren (PTC124) Phase 2 Extension Study
Conditions
Interventions
Ataluren
Start Date
December 31, 2018
Primary Completion Date
January 31, 2021
Completion Date
January 31, 2021
Last Updated
October 7, 2019
NCT05390801
NCT05909735
NCT02647359
Lead Sponsor
PTC Therapeutics
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions